Provided by Tiger Trade Technology Pte. Ltd.

Aura Biosciences, Inc.

7.43
+0.25003.48%
Volume:534.54K
Turnover:3.95M
Market Cap:768.16M
PE:-4.19
High:7.52
Open:7.11
Low:7.11
Close:7.18
52wk High:9.54
52wk Low:4.73
Shares:103.39M
Float Shares:79.92M
Volume Ratio:0.84
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7726
EPS(LYR):-1.7599
ROE:-53.49%
ROA:-31.24%
PB:2.44
PE(LYR):-4.22

Loading ...

Press Release: Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

Dow Jones
·
May 04

Aura Biosciences Inc (AURA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Apr 29

Aura Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 29

Aura Biosciences announces annual shareholder meeting

Reuters
·
Apr 21

Top Aura Biosciences Insider Makes Notable Move With Fresh Stock Sale

TIPRANKS
·
Apr 17

Aura Biosciences price target raised to $15 from $13 at Evercore ISI

TIPRANKS
·
Apr 13

Auranova Raises $1.5 Million in Flow-Through Share Financing for Ontario Gold Exploration

TIPRANKS
·
Apr 08

Auranova Launches Phase 3 Drilling and $1.5 Million Financing at South Uchi Gold Project

TIPRANKS
·
Apr 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)

TIPRANKS
·
Mar 31

Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating

TIPRANKS
·
Mar 31

Aura Biosciences Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 31

Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline

TIPRANKS
·
Mar 30

Aura Biosciences presentation outlines bel-sar phase 3 program in early choroidal melanoma

Reuters
·
Mar 30

Aura Biosciences Q4 EPS $(0.37) Beats $(0.45) Estimate

Benzinga Earnings
·
Mar 30

Aura Biosciences FY25 net loss widens 22.2% to $106M; R&D expense rises to $90M

Reuters
·
Mar 30

BRIEF-Aura Biosciences FY Operating Expenses USD 112.791 Million

Reuters
·
Mar 30

Aura Biosciences FY Net Income USD -106.191 Million

THOMSON REUTERS
·
Mar 30

Press Release: Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Dow Jones
·
Mar 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 30

U.S. Earnings Preview: After Market Close March 27

Dow Jones
·
Mar 28